Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 5 Head & Neck 1 Breast 1

Conditions

Breast Neoplasms 1129 Triple Negative Breast Neoplasms 85 Neoplasm Metastasis 62 Neoplasms 40 Breast Neoplasms, Male 20 Prostatic Neoplasms 19 Carcinoma, Intraductal, Noninfiltrating 19 Neutropenia 18 HER2-positive Breast Cancer 17 Breast Carcinoma In Situ 17 Pain 16 Carcinoma, Ductal, Breast 16 Hot Flashes 15 Lung Neoplasms 14 Inflammatory Breast Neoplasms 14 Breast Diseases 14 Brain Neoplasms 14 Osteoporosis 13 Multiple Myeloma 13 Advanced Breast Cancer 13 Recurrence 12 Ovarian Neoplasms 12 Lymphoma, Non-Hodgkin 11 Lymphoma, Large B-Cell, Diffuse 11 Carcinoma, Ovarian Epithelial 11 Testicular Neoplasms 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, Mantle-Cell 10 Lymphoma, Large-Cell, Immunoblastic 10 Lymphoma, Follicular 10

Interventions

Mastectomy, Subcutaneous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma in Situ × Breast × Clear all

NCT02311959 2026-04-14

MAPAM-01

Institut Claudius Regaud

Phase 3 Completed

Breast Neoplasms, Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡